• Annie Haakenstad, Maxwell Birger, Lavanya Singh, Patrick Liu, Stephen Lim, Marie Ng, and Joseph L Dieleman.
• Annie Haakenstad is a doctoral student at the Harvard T.H. Chan School of Public Health, in Boston, Massachusetts. At the time this research was conducted, she was a project officer at the Institute for Health Metrics and Evaluation (IHME), University of Washington, in Seattle.
• Health Aff (Millwood). 2016 Feb 1; 35 (2): 242-9.

AbstractIn the 2012 Global Vaccine Action Plan, development assistance partners committed to providing sustainable financing for vaccines and expanding vaccination coverage to all children in low- and middle-income countries by 2020. To assess progress toward these goals, the Institute for Health Metrics and Evaluation produced estimates of development assistance for vaccinations. These estimates reveal major increases in the assistance provided since 2000. In 2014, $3.6 billion in development assistance for vaccinations was provided for low- and middle-income countries, up from $822 million in 2000. The funding increase was driven predominantly by the establishment of Gavi, the Vaccine Alliance, supported by the Bill & Melinda Gates Foundation and the governments of the United States and United Kingdom. Despite stagnation in total development assistance for health from donors from 2010 onward, development assistance for vaccination has continued to grow.Project HOPE—The People-to-People Health Foundation, Inc.

22 keywords...

hide…